101 related articles for article (PubMed ID: 20373995)
21. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
22. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
[TBL] [Abstract][Full Text] [Related]
23. [Biomarkers of angiogenesis and endothelial dysfunction in children and adolescents with chronic viral hepatitis.].
Batyrova AS; Vasilieva EM; Bakanov MI; Surkov AN
Klin Lab Diagn; 2019; 64(10):588-593. PubMed ID: 31742950
[TBL] [Abstract][Full Text] [Related]
24. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
Nada O; Abdel-Hamid M; Ismail A; El Shabrawy L; Sidhom KF; El Badawy NM; Ghazal FA; El Daly M; El Kafrawy S; Esmat G; Loffredo CA
J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
[TBL] [Abstract][Full Text] [Related]
25. Serum cytokine levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis.
Costantini S; Capone F; Guerriero E; Maio P; Colonna G; Castello G
Eur Cytokine Netw; 2010 Dec; 21(4):251-6. PubMed ID: 21081303
[TBL] [Abstract][Full Text] [Related]
26. [Relationship between the level of serum TNF-alpha of patients with chronic hepatitis C and treatment with interferon-alpha and the influencing factors].
Ren Y; Duan ZH; Meng QH; Li Z; Li J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):129-31. PubMed ID: 20104757
[TBL] [Abstract][Full Text] [Related]
27. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
28. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?
Hammad LN; Abdelraouf SM; Hassanein FS; Mohamed WA; Schaalan MF
J Immunotoxicol; 2013; 10(4):380-6. PubMed ID: 23350952
[TBL] [Abstract][Full Text] [Related]
29. Cancer biomarker profiling in patients with chronic hepatitis C virus, liver cirrhosis and hepatocellular carcinoma.
Costantini S; Capone F; Maio P; Guerriero E; Colonna G; Izzo F; Castello G
Oncol Rep; 2013 Jun; 29(6):2163-8. PubMed ID: 23564159
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M
J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253
[TBL] [Abstract][Full Text] [Related]
31. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
Knobler H; Zhornicky T; Sandler A; Haran N; Ashur Y; Schattner A
Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828
[TBL] [Abstract][Full Text] [Related]
33. Exploring the Link Between Platelet Numbers and Vascular Homeostasis Across Early and Late Stages of Fibrosis in Hepatitis C.
Ali RO; Moon MS; Townsend EC; Hill K; Zhang GY; Bradshaw A; Guan H; Hamilton D; Kleiner DE; Auh S; Koh C; Heller T
Dig Dis Sci; 2020 Feb; 65(2):524-533. PubMed ID: 31407130
[TBL] [Abstract][Full Text] [Related]
34. Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma.
Tsirakis G; Pappa CA; Kanellou P; Stratinaki MA; Xekalou A; Psarakis FE; Sakellaris G; Alegakis A; Stathopoulos EN; Alexandrakis MG
Hematol Oncol; 2012 Sep; 30(3):131-6. PubMed ID: 21919032
[TBL] [Abstract][Full Text] [Related]
35. Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis.
Mazzanti R; Messerini L; Monsacchi L; Buzzelli G; Zignego AL; Foschi M; Monti M; Laffi G; Morbidelli L; Fantappié O; Bartoloni Saint Omer F; Ziche M
Hepatology; 1997 Jan; 25(1):229-34. PubMed ID: 8985296
[TBL] [Abstract][Full Text] [Related]
36. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
[TBL] [Abstract][Full Text] [Related]
37. Quantitative expression of serum biomarkers involved in angiogenesis and inflammation, in patients with glioblastoma multiforme: correlations with clinical data.
Chiorean R; Berindan-Neagoe I; Braicu C; Florian IS; Leucuta D; Crisan D; Cernea V
Cancer Biomark; 2014; 14(2-3):185-94. PubMed ID: 24878820
[TBL] [Abstract][Full Text] [Related]
38. Expression of vascular endothelial growth factor in human hepatocellular carcinoma.
Yamaguchi R; Yano H; Iemura A; Ogasawara S; Haramaki M; Kojiro M
Hepatology; 1998 Jul; 28(1):68-77. PubMed ID: 9657098
[TBL] [Abstract][Full Text] [Related]
39. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
40. Relationship between tumour necrosis factor-related apoptosis inducing ligand (TRAIL) and vascular endothelial growth factor in human multiple myeloma patients.
Bolkun L; Lemancewicz D; Piszcz J; Moniuszko M; Bolkun-Skornicka U; Szkiladz M; Jablonska E; Kloczko J; Dzieciol J
Hematol Oncol; 2015 Dec; 33(4):199-205. PubMed ID: 25370722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
